Reported Nov 21, 2018 · Terminated

Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical,…

Breckenridge Pharmaceutical, Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Breckenridge Pharmaceutical, Inc. · 6111 Broken Sound Pkwy NW Ste 170 · Boca Raton, FL · 33487-2875

Is this the product you have?

  • Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only
  • Distributed byBreckenridge Pharmaceutical, Inc. Boca Raton, FL 33487
  • Manufactured byPharmaceutics International Inc. Hunt Valley, MD 21031
Lot codes and dates
    • Lot #: 5599.008A
    • 5599.009A
    • 5599.010A
    • Exp. 04/2019
    • 5599.012A
    • 5599.013A
    • Exp. 11/2019
    • 5599.014A
    • Exp. 01/2020
Amount recalled
9,193 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Breckenridge Pharmaceutical, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Nov 26, 2019 · Data as of Sep 19, 6:38 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.